Charles River Laboratories International, Inc. (CRL)
USD 183.16
(-3.26%)
USD 183.16
(-3.26%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 474.62 Million USD | -2.39% |
| 2022 | 486.22 Million USD | 24.36% |
| 2021 | 390.98 Million USD | 7.32% |
| 2020 | 364.3 Million USD | 44.55% |
| 2019 | 252.01 Million USD | 11.33% |
| 2018 | 226.37 Million USD | 83.51% |
| 2017 | 123.35 Million USD | -20.3% |
| 2016 | 154.76 Million USD | 3.65% |
| 2015 | 149.31 Million USD | 17.85% |
| 2014 | 126.69 Million USD | 23.21% |
| 2013 | 102.82 Million USD | 5.69% |
| 2012 | 97.29 Million USD | -11.2% |
| 2011 | 109.56 Million USD | 132.54% |
| 2010 | -336.66 Million USD | -394.19% |
| 2009 | 114.44 Million USD | 121.93% |
| 2008 | -521.84 Million USD | -437.97% |
| 2007 | 154.4 Million USD | 376.8% |
| 2006 | -55.78 Million USD | -139.28% |
| 2005 | 141.99 Million USD | 58.14% |
| 2004 | 89.79 Million USD | 12.03% |
| 2003 | 80.15 Million USD | 59.88% |
| 2002 | 50.13 Million USD | 41.59% |
| 2001 | 35.4 Million USD | 415.46% |
| 2000 | -11.22 Million USD | -165.55% |
| 1999 | 17.12 Million USD | -26.75% |
| 1998 | 23.37 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 89.98 Million USD | 33.65% |
| 2024 Q1 | 67.32 Million USD | -64.01% |
| 2023 Q4 | 187.08 Million USD | 114.08% |
| 2023 Q3 | 87.38 Million USD | -9.93% |
| 2023 Q2 | 97.02 Million USD | -5.93% |
| 2023 FY | 474.62 Million USD | -2.39% |
| 2023 Q1 | 103.13 Million USD | -44.97% |
| 2022 Q1 | 93.02 Million USD | -32.39% |
| 2022 Q3 | 96.47 Million USD | -11.75% |
| 2022 Q4 | 187.41 Million USD | 94.26% |
| 2022 FY | 486.22 Million USD | 24.36% |
| 2022 Q2 | 109.32 Million USD | 17.52% |
| 2021 Q3 | 103.42 Million USD | 16.93% |
| 2021 Q1 | 61.53 Million USD | -57.03% |
| 2021 Q4 | 137.57 Million USD | 33.02% |
| 2021 FY | 390.98 Million USD | 7.32% |
| 2021 Q2 | 88.44 Million USD | 43.75% |
| 2020 Q2 | 67.43 Million USD | 32.83% |
| 2020 FY | 364.3 Million USD | 44.55% |
| 2020 Q4 | 143.19 Million USD | 39.14% |
| 2020 Q3 | 102.9 Million USD | 52.6% |
| 2020 Q1 | 50.76 Million USD | -36.81% |
| 2019 Q4 | 80.34 Million USD | 10.35% |
| 2019 Q1 | 55.13 Million USD | -7.6% |
| 2019 Q2 | 43.72 Million USD | -20.69% |
| 2019 Q3 | 72.81 Million USD | 66.51% |
| 2019 FY | 252.01 Million USD | 11.33% |
| 2018 FY | 226.37 Million USD | 83.51% |
| 2018 Q3 | 60.36 Million USD | 12.4% |
| 2018 Q4 | 59.66 Million USD | -1.16% |
| 2018 Q2 | 53.7 Million USD | 2.05% |
| 2018 Q1 | 52.63 Million USD | 276.32% |
| 2017 Q3 | 52.47 Million USD | -2.74% |
| 2017 Q2 | 53.95 Million USD | 15.34% |
| 2017 Q1 | 46.77 Million USD | 4.7% |
| 2017 Q4 | -29.84 Million USD | -156.88% |
| 2017 FY | 123.35 Million USD | -20.3% |
| 2016 Q4 | 44.68 Million USD | 18.4% |
| 2016 Q1 | 37.14 Million USD | 16.49% |
| 2016 Q3 | 37.73 Million USD | 7.18% |
| 2016 Q2 | 35.2 Million USD | -5.21% |
| 2016 FY | 154.76 Million USD | 3.65% |
| 2015 FY | 149.31 Million USD | 17.85% |
| 2015 Q1 | 31.54 Million USD | 16.1% |
| 2015 Q2 | 48.5 Million USD | 53.8% |
| 2015 Q3 | 37.37 Million USD | -22.94% |
| 2015 Q4 | 31.88 Million USD | -14.7% |
| 2014 Q2 | 35.26 Million USD | 9.41% |
| 2014 Q4 | 27.16 Million USD | -15.2% |
| 2014 FY | 126.69 Million USD | 23.21% |
| 2014 Q1 | 32.23 Million USD | 68.76% |
| 2014 Q3 | 32.03 Million USD | -9.15% |
| 2013 FY | 102.82 Million USD | 5.69% |
| 2013 Q4 | 19.09 Million USD | -38.12% |
| 2013 Q3 | 30.86 Million USD | 13.13% |
| 2013 Q2 | 27.28 Million USD | 6.67% |
| 2013 Q1 | 25.57 Million USD | 38.89% |
| 2012 Q2 | 30.46 Million USD | 15.24% |
| 2012 FY | 97.29 Million USD | -11.2% |
| 2012 Q3 | 21.97 Million USD | -27.88% |
| 2012 Q1 | 26.43 Million USD | -2.49% |
| 2012 Q4 | 18.41 Million USD | -16.18% |
| 2011 Q1 | 31.33 Million USD | 109.12% |
| 2011 Q2 | 32.31 Million USD | 3.14% |
| 2011 Q3 | 18.79 Million USD | -41.83% |
| 2011 Q4 | 27.11 Million USD | 44.24% |
| 2011 FY | 109.56 Million USD | 132.54% |
| 2010 Q2 | 14.45 Million USD | -16.85% |
| 2010 FY | -336.66 Million USD | -394.19% |
| 2010 Q1 | 17.38 Million USD | -1.06% |
| 2010 Q3 | -24.94 Million USD | -272.55% |
| 2010 Q4 | -343.56 Million USD | -1277.51% |
| 2009 FY | 114.44 Million USD | 121.93% |
| 2009 Q1 | 25.4 Million USD | 103.84% |
| 2009 Q2 | 34.15 Million USD | 34.44% |
| 2009 Q3 | 37.31 Million USD | 9.25% |
| 2009 Q4 | 17.56 Million USD | -52.91% |
| 2008 Q4 | -661.88 Million USD | -1555.07% |
| 2008 FY | -521.84 Million USD | -437.97% |
| 2008 Q3 | 45.48 Million USD | -7.29% |
| 2008 Q2 | 49.06 Million USD | 11.16% |
| 2008 Q1 | 44.13 Million USD | 19.59% |
| 2007 Q2 | 37.95 Million USD | 3.25% |
| 2007 FY | 154.4 Million USD | 376.8% |
| 2007 Q1 | 36.76 Million USD | 4.47% |
| 2007 Q3 | 42.77 Million USD | 12.7% |
| 2007 Q4 | 36.91 Million USD | -13.72% |
| 2006 Q4 | 35.18 Million USD | 311.91% |
| 2006 Q1 | -100.11 Million USD | -298.57% |
| 2006 Q2 | 25.74 Million USD | 125.72% |
| 2006 FY | -55.78 Million USD | -139.28% |
| 2006 Q3 | -16.6 Million USD | -164.49% |
| 2005 Q1 | 27.64 Million USD | 37.71% |
| 2005 Q2 | 31.86 Million USD | 15.23% |
| 2005 Q3 | 32.07 Million USD | 0.67% |
| 2005 Q4 | 50.41 Million USD | 57.2% |
| 2005 FY | 141.99 Million USD | 58.14% |
| 2004 FY | 89.79 Million USD | 12.03% |
| 2004 Q1 | 17.59 Million USD | -14.78% |
| 2004 Q2 | 26.3 Million USD | 49.48% |
| 2004 Q3 | 25.82 Million USD | -1.82% |
| 2004 Q4 | 20.07 Million USD | -22.25% |
| 2003 FY | 80.15 Million USD | 59.88% |
| 2003 Q3 | 19.59 Million USD | -4.72% |
| 2003 Q4 | 20.64 Million USD | 5.38% |
| 2003 Q1 | 19.35 Million USD | 10.56% |
| 2003 Q2 | 20.56 Million USD | 6.24% |
| 2002 Q4 | 17.5 Million USD | -5.54% |
| 2002 Q3 | 18.53 Million USD | 13.49% |
| 2002 Q2 | 16.32 Million USD | 831.54% |
| 2002 Q1 | -2.23 Million USD | -125.03% |
| 2002 FY | 50.13 Million USD | 41.59% |
| 2001 Q1 | 6.95 Million USD | 56.98% |
| 2001 FY | 35.4 Million USD | 415.46% |
| 2001 Q4 | 8.91 Million USD | -15.25% |
| 2001 Q3 | 10.52 Million USD | 16.67% |
| 2001 Q2 | 9.01 Million USD | 29.74% |
| 2000 FY | -11.22 Million USD | -165.55% |
| 2000 Q4 | 4.42 Million USD | 118.25% |
| 2000 Q3 | -24.26 Million USD | -404.26% |
| 2000 Q1 | 636 Thousand USD | 0.0% |
| 2000 Q2 | 7.97 Million USD | 1153.77% |
| 1999 FY | 17.12 Million USD | -26.75% |
| 1998 FY | 23.37 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Agilent Technologies, Inc. | 1.24 Billion USD | 61.724% |
| Quest Diagnostics Incorporated | 854 Million USD | 44.423% |
| Danaher Corporation | 4.76 Billion USD | 90.037% |
| Enzo Biochem, Inc. | -26.07 Million USD | 1920.017% |
| IQVIA Holdings Inc. | 1.35 Billion USD | 65.05% |
| Laboratory Corporation of America Holdings | 418 Million USD | -13.546% |
| Mettler-Toledo International Inc. | 788.77 Million USD | 39.828% |
| Qiagen N.V. | 341.3 Million USD | -39.062% |
| Revvity, Inc. | 693.09 Million USD | 31.521% |
| Thermo Fisher Scientific Inc. | 5.99 Billion USD | 92.083% |
| Waters Corporation | 642.23 Million USD | 26.098% |